Gene expression profiles of ABC transporters and cytochrome P450 3A in Caco-2 and human colorectal cancer cell lines

被引:30
作者
Nakamura, T
Sakaeda, T
Ohmoto, N
Moriya, Y
Komoto, C
Shirakawa, T
Gotoh, A
Matsuo, M
Okumura, K [1 ]
机构
[1] Kobe Univ, Sch Med, Dept Hosp Pharm, Chuo Ku, Kobe, Hyogo 6500017, Japan
[2] Kobe Univ, Sch Med, Dept Urol, Chuo Ku, Kobe, Hyogo 6500017, Japan
[3] Kobe Univ, Sch Med, Dept Clin Genet, Chuo Ku, Kobe, Hyogo 6500017, Japan
[4] Kobe Univ, Sch Med, Int Ctr Med Res, Chuo Ku, Kobe, Hyogo 6500017, Japan
关键词
MDR1; multidrug resistance-associated protein (MRP); villin; in vitro screening model;
D O I
10.1023/A:1022251910820
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. The mRNA levels of MDR1 (P-glycoprotein), multidrug resistance-associated proteins (MRP1, MRP2), cytochrome P450 3A (CYP3A) and villin in human colorectal cell lines (HCT-15, LoVo, DLD-1, HCT-116 and SW620) were quantitatively compared with those in Caco-2 cells. Methods. The mRNA levels were determined by real time quantitative polymerase chain reaction and expressed as the relative concentrations of MDR1 mRNA to glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA. Results. MDR1 mRNA was expressed in HCT-15 LoVo and DLD-1 cells at similar or lower level to Caco-2. The expression of MRP1 mRNA in the cell lines tested was comparable with Caco-2. MRP2 mRNA was detected only in HCT-116 and SW620 at significantly lower level than Caco-2. CYP3A mRNA was detected in HCT-15, LoVo, DLD-1 and SW620 at similar level to Caco-2. Conclusions. HCT-15 LoVo and DLD-1 cells express proteins important for regulating the intestinal absorption of drugs, i.e., MDR1, MRP1 and CYP3A, whereas HCT-116 and SW620 cells were not acceptable for evaluation of absorption properties of drug candidates.
引用
收藏
页码:324 / 327
页数:4
相关论文
共 15 条
  • [1] Intestinal drug absorption and metabolism in cell cultures: Caco-2 and beyond
    Artursson, P
    Borchardt, RT
    [J]. PHARMACEUTICAL RESEARCH, 1997, 14 (12) : 1655 - 1658
  • [2] Caco-2 monolayers in experimental and theoretical predictions of drug transport (Reprinted from Advanced Drug Delivery Reviews, vol 22, pg 67-84, 1996)
    Artursson, P
    Palm, K
    Luthman, K
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2001, 46 (1-3) : 27 - 43
  • [3] The drug efflux-metabolism alliance: biochemical aspects
    Benet, LZ
    Cummins, CL
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2001, 50 : S3 - S11
  • [4] Boulenc X, 1997, STP PHARMA SCI, V7, P259
  • [5] Characterizing the expression of CYP3A4 and efflux transporters (P-gp, MRP1, and MRP2) in CYP3A4-transfected Caco-2 cells after induction with sodium butyrate and the phorbol ester 12-O-tetradecanoylphorbol-13-acetate
    Cummins, CL
    Mangravite, LM
    Benet, LZ
    [J]. PHARMACEUTICAL RESEARCH, 2001, 18 (08) : 1102 - 1109
  • [6] CYP3A4, CYP3A5, and MDR1 in human small and large intestinal cell lines suitable for drug transport studies
    Engman, HA
    Lennernäs, H
    Taipalensuu, J
    Otter, C
    Leidvik, B
    Artursson, P
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 2001, 90 (11) : 1736 - 1751
  • [7] Carrier-mediated transport and efflux mechanisms in Caco-2 cells
    Hidalgo, IJ
    Li, JB
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 1996, 22 (1-2) : 53 - 66
  • [8] Hirohashi T, 2000, J PHARMACOL EXP THER, V292, P265
  • [9] Multiple physiological functions for multidrug transporter P-glycoprotein?
    Johnstone, RW
    Ruefli, AA
    Smyth, MJ
    [J]. TRENDS IN BIOCHEMICAL SCIENCES, 2000, 25 (01) : 1 - 6
  • [10] Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine
    Lown, KS
    Mayo, RR
    Leichtman, AB
    Hsiao, HL
    Turgeon, DK
    SchmiedlinRen, P
    Brown, MB
    Guo, WS
    Rossi, SJ
    Benet, LZ
    Watkins, PB
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 62 (03) : 248 - 260